Aortyx secures €13.8M in Series A funding led by Ship2B Ventures to develop a life-saving vascular patch for treating aortic dissections.

Aortyx secures €13.8M in Series A funding led by Ship2B Ventures to develop a life-saving vascular patch for treating aortic dissections.

06/12/25, 7:18 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/ES.svgteia
Money raised
€13.8 million
Industry
biotechnology
health care
Round Type
series a
Investors
Axis, Eif, Banco Sabadell, B Social Impact Fund, Ship2 B Ventures
Aortyx has raised €13.8 million in a Series A funding round to advance its innovative solution for aortic dissection. The company aims to provide a minimally invasive approach to treating this critical condition. This funding will help Aortyx achieve first-in-human testing within two years. Ship2B Ventures is the lead investor for this round.

Company Info

Company
Aortyx
Location
teia, barcelona, spain
Additional Info
Aortyx is a pioneer company focused on developing new medical devices for vascular repair. Our mission is to deliver the best available treatments to our patients with the most advanced available technology.

Related People